Anavex Life Sciences (AVXL) Breakout Alert: Should You Buy?

It is often a good idea to look into a stock that has made gains over a reasonable period of time and that brings us to the subject of the Anavex Life Sciences Corp (NASDAQ: AVXL) stock.

The Anavex stock has performed impressively over the course of the past two weeks and during that period, it has managed to record gains of as big as 100%. While it may be true that there has not been any recent news about the company’s business, there are certain developments from the past which cannot be ignored.

Related:  Cresco Labs (CRLBF) Trades Near Highs: Buy Now?

Back on January 11 this year, it was announced that the company was awarded a grant worth $995,862.51 by The Michael J. Fox Foundation for Parkinson’s Research. The grant in question is meant for funding the clinical study into the company’s product Anavex 2-73. The product in question is meant for treating Parkinson’s disease. The funding is a significant boost to the company and the continued rally in the stock is perhaps understandable.

Uson Abdilazhanov

Editor and Computer Expert A hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.